A carregar...

Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis

The contribution of Th17 cells to the development of colitis is well described. The effector cytokines IL-17A and IL-17F have been proposed as potential therapeutic targets for the treatment of patients with inflammatory bowel disease. In a proof-of-concept study for the treatment of patients with C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McLean, Leon P, Cross, Raymond K, Shea-Donohue, Terez
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3857957/
https://ncbi.nlm.nih.gov/pubmed/23998727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.13.87
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!